Some studies have shown that DZNep exhibits good anti-tumor properties by inhibiting EZH2 in breast cancer [95], lung cancer [96], prostate cancer [97], colon cancer [98], and other cancer cells. The gene discussed is EZH2; the disease is lung carcinoma.